Bastit P - Search Results

1

Pirarubicin in advanced breast cancer: a French cooperative phase II study.

Spielmann M, Kerbrat P, Delozier T, Fumoleau P, Monnier A, Chevallier B, Bastit P, Namer M, Cattan A, Lucas P, et al. Spielmann M, et al. Among authors: bastit p. Eur J Cancer. 1990;26(7):821-3. doi: 10.1016/0277-5379(90)90161-l. Eur J Cancer. 1990. PMID: 2145903

2

Phase II study of oral idarubicin in elderly patients with advanced breast cancer.

Chevallier B, Monnier A, Metz R, Namer M, Marty M, Roche H, Bastit P, Hurteloup P. Chevallier B, et al. Among authors: bastit p. Am J Clin Oncol. 1990 Oct;13(5):436-9. doi: 10.1097/00000421-199010000-00015. Am J Clin Oncol. 1990. PMID: 2220664

3

Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck.

Cappelaere P, Guiochet N, Chauvergne J, Bastit P, Armand JP, Lentz MA, Van Glabbeke M, Herait P, Fumoleau P. Cappelaere P, et al. Among authors: bastit p. Eur J Cancer. 1992;28(2-3):484-5. doi: 10.1016/s0959-8049(05)80083-8. Eur J Cancer. 1992. PMID: 1591069 Clinical Trial. No abstract available.

4

Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer.

Bonneterre J, Kerbrat P, Fargeot P, Metz R, Roche H, Bastit P, Chevrier A, Tubiana-Hulin M, Geyer G, Cappelaere P. Bonneterre J, et al. Among authors: bastit p. Eur J Cancer. 1991;27(7):849-52. doi: 10.1016/0277-5379(91)90132-w. Eur J Cancer. 1991. PMID: 1834115 Clinical Trial.

5

[Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer].

Fumoleau P, Bastit P, Horner D, Chauvergne J, Metz R, Bugat R, Cappelaere P. Fumoleau P, et al. Among authors: bastit p. Bull Cancer. 1990;77(8):805-10. Bull Cancer. 1990. PMID: 2207369 Clinical Trial. French.

6

Phase II study of epirubicin in advanced soft tissue sarcoma.

Chevallier B, Montcuquet P, Fachini T, Nguyen Bui B, Kerbrat P, Bastit P, Vo Van ML. Chevallier B, et al. Among authors: bastit p. Bull Cancer. 1990;77(10):991-5. Bull Cancer. 1990. PMID: 2249019

7

Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of Cancer.

Hurteloup P, Armand JP, Schneider M, Bastit P, Chevallier B, Pourny C, Keiling R, de Oliveira C, Hayat M, Thomas D, et al. Hurteloup P, et al. Among authors: bastit p. Eur J Cancer Clin Oncol. 1989 Mar;25(3):423-8. doi: 10.1016/0277-5379(89)90254-x. Eur J Cancer Clin Oncol. 1989. PMID: 2702996

8

[Adjuvant chemotherapy of breast cancer].

Chevallier B, Bastit P. Chevallier B, et al. Among authors: bastit p. Presse Med. 1986 May 3;15(18):835-8. Presse Med. 1986. PMID: 2940539 Review. French.

9

[Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].

Comoz M, Chevallier B, Bastit P. Comoz M, et al. Among authors: bastit p. Bull Cancer. 1988;75(3):281-3. Bull Cancer. 1988. PMID: 3130910 French.

10

Serum hyaluronan (hyaluronic acid) in breast cancer patients.

Delpech B, Chevallier B, Reinhardt N, Julien JP, Duval C, Maingonnat C, Bastit P, Asselain B. Delpech B, et al. Among authors: bastit p. Int J Cancer. 1990 Sep 15;46(3):388-90. doi: 10.1002/ijc.2910460309. Int J Cancer. 1990. PMID: 2394505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters